Drug Details
Acthar® Gel (repository corticotropin injection) is FDA approved for the treatment of people with symptoms of sarcoidosis.
Study Purpose
The purpose of this study is to evaluate the efficacy and safety of H.P. Acthar® Gel (Acthar) in the treatment of pulmonary sarcoidosis.
